US FDA医疗器械产业转型中实现的奇异长期类库兹涅茨期:1976 - 2020年创新视角
Singular Secular Kuznets-like Period Realized Amid Industrial Transformation in US FDA Medical Devices: A Perspective on Innovation from 1976 to 2020
摘要:
简介:自成立以来,美国(US)食品药品监督管理局(FDA)一直保持着受监管医疗器械(MD)的稳健记录。基于这些数据,我们能否洞察行业的创新动态,包括产业转型的潜力?涵盖领域:使用上市前批准(PMN)和批准(PMA)数据,显示从1976年到2020年,(PMN + PMA)指标遵循单一长期期:20.5年(申请量高峰期:1992-2012年;低谷期:2002年)和26.5年(登记峰-峰:1992年至2019年;谷:2003年),峰-谷相对百分比差异分别为24%和28%。重要的是,PMN和PMA独立地呈现为逆结构。专家意见:证据表明:MD创新是由一个单一的长期的库内特样循环现象(独立于经济危机)从一个根本性的转变,从简单的(PMNs)到复杂的(PMA)MD。值得注意的是,虽然COVID-19危机可能不会影响压倒一切的动态,但预期的重大(约25%)MD创新下降可能会随着MD利益相关者的关注措施而减弱。这种方法的局限性和进一步的思考完成了这一观点。
英文摘要:
Introduction: Since inception, the United States (US) Food and Drug Administration (FDA) has kept a robust record of regulated medical devices (MDs). Based on these data, can we gain insight into the innovation dynamics of the industry, including the potential for industrial transformation? Areas Covered: Using Premarket Notifications (PMNs) and Approvals (PMAs) data, it is shown that from 1976 to 2020 the total composite (PMN + PMA) metric follows a single secular period: 20.5 years (applications peak-to-peak: 1992-2012; trough: 2002) and 26.5 years (registrations peak to peak: 1992 to 2019; trough: 2003), with a peak to trough relative percentage difference of 24% and 28%, respectively. Importantly, PMNs and PMAs independently present as an inverse structure. Expert Opinion: The evidence suggests: MD innovation is driven by a singular secular Kutnets-like cyclic phenomenon (independent of economic crises) derived from a fundamental shift from simple (PMNs) to complex (PMAs) MDs. Portentously, while the COVID-19 crisis may not affect the overriding dynamic, the anticipated yet significant (~25%) MD innovation drop may be potentially attenuated with attentive measures by MD stakeholders. Limitations of this approach and further thoughts complete this perspective.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。